Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Pandora Media Inc (P): Sirius XM Radio Inc (SIRI) Is No Miley Cyrus

A day after Miley Cyrus shocked and amused the music industry with her risque performance at Sunday night’s MTV Video Music Awards, Sirius XM Radio Inc (NASDAQ:SIRI) was being accused by the music industry for not going far enough.

SoundExchange became the latest party to sue the satellite radio provider on Monday, arguing that Sirius XM Radio Inc (NASDAQ:SIRI) has been cheating the music royalty collector since 2007 by the way that it calculates its gross revenue. The statutory rate was 8% of gross revenue last year, but Sirius XM excludes several revenue items including non-music programming, hardware sales, and the airplay of pre-1972 recordings.

Sirius XM Radio Inc (NASDAQ:SIRI)

It was that final point that triggered a lawsuit initiated by The Turtles’ Flo and Eddie earlier this month to collect money for older music artists and their estates.

Record labels and radio stations used to be a team, but these days we’re finding Sirius XM Radio Inc (NASDAQ:SIRI) and Pandora Media Inc (NYSE:P) battling the industry in a pursuit to drive rates lower. This wouldn’t be such a big deal if terrestrial radio was getting off so easy with its kinder royalty schedules.

Sirius XM Radio Inc (NASDAQ:SIRI) has never shied away from legal fisticuffs, and that means also battling in the courtroom with on-air talent and subscribers.

Howard Stern and his production company came after Sirius XM Radio Inc (NASDAQ:SIRI) for subscriber count-based stock bonuses after the merger between Sirius and XM. The satellite radio provider prevailed. A suit started by disgruntled subscribers concerning rate increases was ultimately settled on terms that were friendly to Sirius XM.

Big media companies are lawyer magnets, but it’s safe to say that the artist royalty issue isn’t going to die anytime soon. SoundExchange is seeking compensatory damages that could top $100 million if it’s successful.

However, all of these legal tussles also point to a royalty and licensing system that is out of whack if new models are to succeed for the benefit of the industry as a whole. A company shouldn’t have to buy a small South Dakota radio station — as Pandora Media Inc (NYSE:P) did earlier this year — in a brazen attempt to secure the lower rates that are available to others.

Sirius XM shareholders won’t like the uncertainty of the media giant getting sued, but the end result could be bullish if it makes royalties more palatable for the growing media players out there.

Cyrus sang about blurred lines on Sunday night, and that’s a problem in more ways than one.

The article Sirius XM Is No Miley Cyrus originally appeared on and is written by Rick Munarriz.

Longtime Fool contributor Rick Munarriz has no position in any stocks mentioned. The Motley Fool recommends Pandora Media (NYSE:P).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.